Mary Royal, a 54-year-old mother of four, received a diagnosis of multicentric breast cancer in 2023, a diagnosis which ...

Letter, Dr. Jenni Sheng, an Assistant Professor in the Department of Oncology at the Hopkins School of Medicine, discussed ...

The 5-Year Risk Score: New AI tools can analyze your current “normal” tissue to identify hidden biomarkers of future risk.

A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier diagnosis and improved survival pending further studies. Scientists backed by the ( ...

Artificial intelligence (AI)-supported mammography identifies more cancers during screening and reduces the rate of breast cancer diagnosis by 12% in the years following, finds the first randomized ...

Women at high risk of developing breast cancer between regular check-ups have been identified using AI technology. Cambridge University researchers showed the potential of a new AI tool to help ...

The point of breast self-awareness is to “know what your breasts normally look and feel like. And if something changes and ...

Women who missed their first screening mammogram had a 53% higher risk of stage III breast cancer over the next 25 years and almost a fourfold higher risk of stage IV breast cancer. Breast cancer ...

LYNCHBURG, Va. (WDBJ) - A new law will make breast cancer screenings more affordable for Virginians. The new law removes significant financial hurdles that could cost lives because women could not ...

A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms for all, women were screened based on genetics, health history, and ...

A new study suggests that annual mammograms may not be the only effective approach for preventing breast cancer. The research, published in the Journal of the American Medical Association (JAMA), ...

Dec 15 (Reuters) - The U.S. Food and Drug Administration has approved AstraZeneca (AZN.L), opens new tab and partner Daiichi Sankyo's (4568.T), opens new tab Enhertu in combination with Roche's (ROG.S ...